Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic Cancer

Siegel, 2016, Cancer statistics, 2016., CA Cancer J Clin, 66, 7, 10.3322/caac.21332

Strobel, 2019, Optimizing the outcomes of pancreatic cancer surgery., Nat Rev Clin Oncol, 16, 11, 10.1038/s41571-018-0112-1

Hammel, 2016, Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial., JAMA, 315, 1844, 10.1001/jama.2016.4324

Loehrer, 2011, Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial., J Clin Oncol, 29, 4105, 10.1200/JCO.2011.34.8904

Chauffert, 2008, Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study., Ann Oncol, 19, 1592, 10.1093/annonc/mdn281

Rudra, 2019, Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer., Cancer Med, 8, 2123, 10.1002/cam4.2019.8.issue-5

Krishnan, 2016, Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation., Int J Radiat Oncol Biol Phys, 94, 755, 10.1016/j.ijrobp.2015.12.003

Reyngold, 2019, Ablative radiation therapy for locally advanced pancreatic cancer: techniques and results., Radiat Oncol, 14, 95, 10.1186/s13014-019-1309-x

Suker, 2016, FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis., Lancet Oncol, 17, 801, 10.1016/S1470-2045(16)00172-8

Neoptolemos, 2017, Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial., Lancet, 389, 1011, 10.1016/S0140-6736(16)32409-6

Mollberg, 2011, Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis., Ann Surg, 254, 882, 10.1097/SLA.0b013e31823ac299

Bhayani, 2014, Multivisceral and extended resections during pancreatoduodenectomy increase morbidity and mortality., Surgery, 155, 567, 10.1016/j.surg.2013.12.020

Kulemann, 2015, Perioperative and long-term outcome after standard pancreaticoduodenectomy, additional portal vein and multivisceral resection for pancreatic head cancer., J Gastrointest Surg, 19, 438, 10.1007/s11605-014-2725-8

Cloyd, 2016, Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma., Cancer, 122, 2671, 10.1002/cncr.v122.17